DIRECT Chemist Outlet (DCO) has announced a significant enhancement in its supply chain through a new two-year agreement with Arrotex Pharmaceuticals.
The partnership aims to bolster DCO's access to a broad spectrum of generic medications, emphasising the company's commitment to cost-effective healthcare solutions for its customers.
Ian Tauman, Director of DCO, expressed enthusiasm about the collaboration, highlighting Arrotex's alignment with the banner group's mission of providing accessible healthcare nationwide.
Additionally, DCO acknowledged its fruitful decade-long relationship with its previous supplier, pharma company Sandoz.
The strategic move with Arrotex marks a key development in DCO's expansion within the Australian pharmaceutical market, helping the group to solidifying its supply chain for accessibility, and quality.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 May 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 May 24
